Pharmasset Inc. (VRUS): Today's Featured Drugs Loser
(
) pushed the Drugs industry lower today making it today's featured Drugs loser. The industry as a whole closed the day up 3.6%. By the end of trading, Pharmasset Inc fell $1.44 (-1.1%) to $130.99 on heavy volume. Throughout the day, 6.8 million shares of Pharmasset Inc exchanged hands as compared to its average daily volume of 1.9 million shares. The stock ranged in price between $130.40-$132.50 after having opened the day at $132.50 as compared to the previous trading day's close of $132.43. Other company's within the Drugs industry that declined today were:
(
), down 14.4%,
(
), down 12.7%,
(
), down 9.1%, and
(
), down 8.1%.
Pharmasset, Inc., a clinical-stage pharmaceutical company, engages in discovering, developing, and commercializing novel drugs to treat viral infections. Pharmasset Inc has a market cap of $10.09 billion and is part of the
sector. Shares are up 508% year to date as of the close of trading on Tuesday.
TheStreet Ratings rates Pharmasset as a
. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, weak operating cash flow and deteriorating net income.
- You can view the full Pharmasset Ratings Report.
On the positive front,
(
), up 21.4%,
(
), up 20.9%,
(
), up 19.2%, and
(
), up 18.4%, were all gainers within the drugs industry with
(
) being today's featured drugs industry winner.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the drugs industry could consider
(
) while those bearish on the drugs industry could consider
ProShares UltraShort Nasdaq Biotech
(
).
- Find other investment ideas from our top rated ETFs lists.
null
